Annual report [Section 13 and 15(d), not S-K Item 405]

STOCKHOLDERS' EQUITY

v3.25.4
STOCKHOLDERS' EQUITY
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
STOCKHOLDERS' EQUITY

12. STOCKHOLDERS’ EQUITY

Forward Sale Agreements

On October 21, 2024, in connection with the execution of the Sandy Spring merger agreement, the Company entered into an initial forward sale agreement with Morgan Stanley & Co. LLC (the “Forward Purchaser”) relating to an aggregate of 9,859,155 shares of the Company’s common stock. On October 21, 2024, the Company priced the public offering of shares of the Company’s common stock in connection with such forward sale agreement and entered into an underwriting agreement with Morgan Stanley & Co. LLC, as representative for the underwriters named therein, the Forward Purchaser and Morgan Stanley & Co. LLC as forward seller (the “Forward Seller”), relating to the registered public offering and sale of 9,859,155 shares of the Company’s common stock at a public offering price of $35.50 per share (before underwriting discounts and commissions). The underwriters were granted a 30-day option to purchase up to an additional 1,478,873 shares of the Company’s common stock. On October 21, 2024, the underwriters exercised in full their option to purchase the additional 1,478,873 shares of the Company’s common stock pursuant to the underwriting agreement and, in connection therewith, the Company entered into an additional forward sale agreement with the Forward Purchaser relating to 1,478,873 shares of the Company’s common stock, on terms substantially similar to those contained in the initial forward sale agreement (such additional forward sale agreement together with the initial forward sale agreement, the “Forward Sale Agreements”).

On April 1, 2025, the Company physically settled in full the Forward Sale Agreements by delivering 11,338,028 shares of the Company’s common stock to the Forward Purchaser. The Company received net proceeds from such sale of shares of the Company’s common stock and full physical settlement of the Forward Sale Agreements, before expenses, of approximately $385.0 million.

Share Repurchase Programs

The Company’s share repurchase program activity is dependent on management’s determination of its capital deployment needs, subject to market, economic, and regulatory conditions. Authorized repurchase programs allow the Company to repurchase its common stock through either open market transactions or privately negotiated transactions. There have been no active share repurchase programs in 2025, 2024, or 2023.

Series A Preferred Stock

The Company has 6,900,000 depositary shares outstanding, each representing a 1/400th ownership interest in a share of its Series A preferred stock, with a liquidation preference of $10,000 per share of Series A preferred stock (equivalent to $25 per depositary share), including 900,000 depositary shares pursuant to the exercise in full by the underwriters of their option to purchase additional depositary shares. Series A preferred stock dividends, if declared by the Board or a fully authorized committee of the Board, are paid by the Company in arrears on the first business day of March, June, September, and December of each year at a rate of 6.875% per annum.

Accumulated Other Comprehensive Income (Loss)

The change in accumulated other comprehensive income (“AOCI”) (loss) for the year ended December 31, 2025 is summarized as follows, net of tax (dollars in thousands):

  ​ ​ ​

  ​ ​ ​

Unrealized

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Gains

(Losses) for 

Unrealized

AFS 

Unrealized 

Gains (Losses) 

Securities 

Change in Fair

Gains 

on AFS 

Transferred 

Value of Cash 

(Losses) 

Securities

to HTM

Flow Hedges

on BOLI

Total

AOCI (loss) - December 31, 2024

$

(317,142)

$

$

(43,078)

$

534

$

(359,686)

Other comprehensive (loss) income:

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

Other comprehensive income before reclassification

 

82,377

 

 

21,913

 

39

 

104,329

Amounts reclassified from AOCI into earnings

 

63

 

 

 

(793)

 

(730)

Net current period other comprehensive income (loss)

 

82,440

 

 

21,913

 

(754)

 

103,599

AOCI (loss) - December 31, 2025

$

(234,702)

$

$

(21,165)

$

(220)

$

(256,087)

The change in AOCI (loss) for the year ended December 31, 2024 is summarized as follows, net of tax (dollars in thousands):

  ​ ​ ​

  ​ ​ ​

Unrealized

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Gains 

(Losses) for 

Unrealized 

AFS 

Unrealized 

Gains (Losses) 

Securities 

Change in Fair

Gains 

on AFS 

Transferred 

Value of Cash 

(Losses) on

Securities

to HTM

Flow Hedges

BOLI

Total

AOCI (loss) - December 31, 2023

$

(302,532)

$

6

$

(42,165)

$

1,342

$

(343,349)

Other comprehensive (loss) income:

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

Other comprehensive loss before reclassification

 

(19,739)

 

 

(913)

 

(16)

 

(20,668)

Amounts reclassified from AOCI into earnings

 

5,129

 

(6)

 

 

(792)

 

4,331

Net current period other comprehensive loss

 

(14,610)

 

(6)

 

(913)

 

(808)

 

(16,337)

AOCI (loss) - December 31, 2024

$

(317,142)

$

$

(43,078)

$

534

$

(359,686)

The change in AOCI (loss) for the year ended December 31, 2023 is summarized as follows, net of tax (dollars in thousands):

  ​ ​ ​

  ​ ​ ​

Unrealized

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Gains 

(Losses) for 

Unrealized 

AFS 

Unrealized

Gains (Losses) 

Securities 

Change in Fair

Gains 

on AFS 

Transferred 

Value of Cash 

(Losses) 

Securities

to HTM

Flow Hedges

on BOLI

Total

AOCI - December 31, 2022

$

(363,919)

$

17

$

(54,610)

$

226

$

(418,286)

Other comprehensive (loss) income:

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

Other comprehensive income before reclassification

 

29,006

 

 

12,445

 

10

 

41,461

Amounts reclassified from AOCI into earnings

 

32,381

 

(11)

 

 

1,106

 

33,476

Net current period other comprehensive income (loss)

 

61,387

 

(11)

 

12,445

 

1,116

 

74,937

AOCI (loss) - December 31, 2023

$

(302,532)

$

6

$

(42,165)

$

1,342

$

(343,349)